ImmuCell Corp (NASDAQ: ICCC) stock suffered a major decline of -10.9% on 5/15/24. The shares closed at $4.88. Moreover, trading volume in this decline was exceptionally high at 659% of normal. The stock has performed in line with the market over the last nine months and has declined -4.5% during the last week.
Current PriceTarget Research Rating
ICCC is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
ImmuCell has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. ImmuCell has a neutral Power Rating of 41 but a very low Appreciation Score of 12, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment